MARATTO

article · Naunyn-Schmiedeberg s Archives of Pharmacology

Fondaparinux attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and inflammatory signaling via the TLR4/NLRP3 and NF-κB/IL-1β/MCP-1 pathways

2026Al-Azhar University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Drug-Induced Hepatotoxicity and Protection
  • Chemotherapy-induced organ toxicity mitigation
  • Liver Disease and Transplantation

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1007/s00210-026-05304-x

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.